Technology News and Research

RSS

Integral Molecular announces new patent protecting use of lipoparticles for eliciting antibodies against protein targets

Integral Molecular, a leader in membrane protein antibody discovery, announces the issuance of a new patent protecting the use of Lipoparticles for eliciting antibodies against membrane protein targets.

29 Mar 2014

ATHENA develops surrogate organ system for toxicity testing

Creating surrogate human organs, coupled with insights from highly sensitive mass spectrometry technologies, a new project is on the brink of revolutionizing the way we screen new drugs and toxic agents.

29 Mar 2014

Toshiba launches CardioLine software for faster and more accurate MR cardiac exams

MR cardiac exams are faster and more accurate with new tools from Toshiba America Medical Systems, Inc. CardioLine, now available on the Vantage Titan™ 1.5T and 3T MR systems, improves workflow and standardizes exams to meet the pressures of today's cardiology market.

29 Mar 2014

RXi Pharmaceuticals provides business update, reports Q4 and full year 2013 financial results

RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today reported its financial results for the full year 2013, and provided a business update.

29 Mar 2014

New research reports on China Dental Care market and China mask industry

MarketReportsChina.com adds "Research and Forecast of China Oral Care (Dental) Industry, 2014" and "Research and Investment Prospects of China Mask Industry, 2014-2018" reports to its research database.

29 Mar 2014

Nordion enters into definitive agreement to be acquired by Sterigenics

Nordion Inc., a leading provider of products and services to the global health science market, announced that it has entered into a definitive agreement (the "Arrangement Agreement") to be acquired by Sterigenics, a global leader in sterilization services and a portfolio company of GTCR LLC, a leading private equity firm based in Chicago, Illinois, USA.

29 Mar 2014

Pollution from agricultural sources poses larger health costs than previously estimated

Ammonia pollution from agricultural sources poses larger health costs than previously estimated, according to NASA-funded research.

29 Mar 2014

MD Anderson's Jim Allison honored with 2014 Canada Gairdner International Award

A Canadian institution that annually recognizes seminal medical discoveries selected cancer immunotherapy leader Jim Allison, Ph.D., chair and professor of Immunology at The University of Texas MD Anderson Cancer Center, for one of its 2014 Canada Gairdner International Awards.

29 Mar 2014

Parlance announces new partnership with Doctors Community Hospital

Parlance Corporation today announced a new partnership with Doctors Community Hospital (DCH) of Lanham, MD. The 219 bed community hospital has implemented Parlance's Operator Assistant™ automated call handling solution to improve service levels to callers, manage operator call load, and reduce operator services costs.

29 Mar 2014

Royal Philips to present innovative imaging and informatics solutions at ACC 2014

Royal Philips today announced its participation in the American College of Cardiology Conference Annual Meeting in Washington, D.C., where it will present the innovative imaging and informatics solutions that are helping clinicians deliver timely diagnoses and minimally-invasive treatments to a growing cardiovascular patient population.

From Philips Healthcare 28 Mar 2014

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

North Shore InnoVentures, one of New England's leading technology incubators and business accelerators, announced today that it has received a capital grant of $1.65 million from the Massachusetts Life Sciences Center.

From Evident Corporation - Life Sciences 28 Mar 2014

EC approves Roche's SC formulation of MabThera for common forms of non-Hodgkin lymphoma

Halozyme Therapeutics, Inc. announced today that the European Commission has approved Roche's new subcutaneous (SC) formulation of MabThera (rituximab) for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma.

28 Mar 2014

Veterans who suffer from "Gulf War illness" have impaired function of mitochondria

Researchers at the UC San Diego School of Medicine have demonstrated for the first time that veterans of the 1990-91 Persian Gulf War who suffer from "Gulf War illness" have impaired function of mitochondria - the energy powerhouses of cells.

28 Mar 2014

Cambridge Business Innovation Award for Crescendo Biologics

Crescendo Biologics Limited (Crescendo) today announces it has been awarded the prize for Business Innovation at the Cambridge News Business Excellence Awards 2014.

28 Mar 2014

ADMA Biologics reports consolidated net loss of $15.5M in 2013

ADMA Biologics, Inc., a late-stage biopharmaceutical company that develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, today announced its financial results for the year ended December 31, 2013 and provided recent company developments as well as anticipated milestones for 2014.

28 Mar 2014

State highlights: Parents of disabled kids blast Minnesota Gov.; N.Y. reins in tanning salon claims

A tearful mother, one of several who testified at a State Capitol press conference Wednesday to make an impassioned plea for a medical marijuana law, said that Gov. Mark Dayton had earlier suggested to her and others that they obtain the drug illegally.

28 Mar 2014

GenVec's revenues decrease 61% to $3.7M in fourth quarter 2013

GenVec, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013. For the year ended December 31, 2013, the company reported a net loss of $10.0 million, or $0.77 per share, compared with a net loss of $14.1 million, or $1.09 per share, for the year ended December 31, 2012.

28 Mar 2014

Longer looks: Exercise to treat depression; crowdsourcing treatment decisions; nitroglycerin shortage

Depression is the most common mental illness - affecting a staggering 25 percent of Americans - but a growing body of research suggests that one of its best cures is cheap and ubiquitous.

28 Mar 2014

World of digital health changing global healthcare landscape

The 4th Mobile and Wearable Technology: Healthcare 2014 Conference will be taking place from 3 – 4 April 2014 in Singapore at the Parkroyal Hotel.

From Medtronic 28 Mar 2014

Simple chip-based method for better diagnosis of parasitic infections

Parasitic infections like malaria and sleeping sickness affect hundreds of millions of people, primarily in the poorest regions of the world. Diagnosis of these diseases is often difficult because the concentration of parasites in the blood can be very low.

28 Mar 2014

Technology News and Research

Integral Molecular announces new patent protecting use of lipoparticles for eliciting antibodies against protein targets

ATHENA develops surrogate organ system for toxicity testing

Toshiba launches CardioLine software for faster and more accurate MR cardiac exams

RXi Pharmaceuticals provides business update, reports Q4 and full year 2013 financial results

New research reports on China Dental Care market and China mask industry

Nordion enters into definitive agreement to be acquired by Sterigenics

Pollution from agricultural sources poses larger health costs than previously estimated

MD Anderson's Jim Allison honored with 2014 Canada Gairdner International Award

Parlance announces new partnership with Doctors Community Hospital

Royal Philips to present innovative imaging and informatics solutions at ACC 2014

Massachusetts Life Sciences Center provides $1.65M in capital grant to North Shore InnoVentures

EC approves Roche's SC formulation of MabThera for common forms of non-Hodgkin lymphoma

Veterans who suffer from "Gulf War illness" have impaired function of mitochondria

Cambridge Business Innovation Award for Crescendo Biologics

ADMA Biologics reports consolidated net loss of $15.5M in 2013

State highlights: Parents of disabled kids blast Minnesota Gov.; N.Y. reins in tanning salon claims

GenVec's revenues decrease 61% to $3.7M in fourth quarter 2013

Longer looks: Exercise to treat depression; crowdsourcing treatment decisions; nitroglycerin shortage

World of digital health changing global healthcare landscape

Simple chip-based method for better diagnosis of parasitic infections

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News